---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-036573"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:49:41.773210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shareholders re-elect director, approve 3-year say-on-pay frequency, ratify auditor

## Summary
- Eric Friedman re-elected as Class III director with 20.66M votes for, 183k withheld, and 1.81M broker non-votes.
- Non-binding advisory vote: 20.40M shares favor 3-year frequency for executive compensation votes.
- Executive compensation say-on-pay approved: 20.79M for, 56,978 against, 700 abstain.
- Ratification of CBIZ CPAs P.C. as independent auditors for FY2026: 22.54M for, 113k against, 1,138 abstain.

## SEC filing metadata
- accession: 0001437749-25-036573
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/0001437749-25-036573-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774925036573/inbp20251201_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-036573
- JSON: https://secwatch.observer/filing/0001437749-25-036573.json
- Plain text: https://secwatch.observer/filing/0001437749-25-036573.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.